Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02087241 |
| Title | Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | AstraZeneca |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Research Site | Englewood | Colorado | United States | Details | ||
| Research Site | Fort Myers | Florida | United States | Details | ||
| Research Site | Orlando | Florida | United States | Details | ||
| Research Site | Peoria | Illinois | United States | Details | ||
| Research Site | Fort Wayne | Indiana | United States | Details | ||
| Research Site | Wichita | Kansas | United States | Details | ||
| Research Site | Cincinnati | Ohio | United States | Details | ||
| Research Site | Nashville | Tennessee | United States | Details |